Enrico Bucci was born in Naples, Italy, in 1972. He graduated summa cum laude in Biology in 1997 (University of Naples “Federico II,” Italy). After four years as a Ph.D. student, comprising two years in Germany (Institut für Molekulare Biotechnologie, Jena, now called the Leibniz Institute on Aging – Fritz Lipmann Institute), he earned a Ph.D. in Biochemistry and Molecular Biology in 2001 by the Naples University “Federico II” (Italy). The same year he was appointed full researcher at the Institute for Biostructures and Bioimages of Italy’s National Research Council (CNR). 

In 2006, he founded his first start-up, BioNucleon Srl, which won the “2006 Best Young and Innovative Italian company” and was dedicated to nucleic acid-based drugs. It was incubated at the Canavese Bioindustry Park. Enrico Bucci then became CSO of the Park, heading a group of about 20 scientists which filed more than tenpatent applications and published several research papers, while still running Bionucleon. By the end of 2008, after honoring all commitments related to its previous role, Enrico Bucci moved to become CSO of Biodigitalvalley Srl, his second start-up, dedicated to bioinformatics. In January 2013, he was appointed CEO. 

In 2012, he got the Italian abilitation for a position of Associate Professor in Biochemistry (Abilitazione Nazionale 2012 – Settore Concorsuale 05/E1 – II Fascia -2012 – valid until 16/06/2023).

In July 2014, he voluntarily resigned from the CNR, since at the time he was investigating a high-profile case of scientific misconduct involving that institution.

In June 2016, he was appointed Adjunct Professor of Biology and Director of the System Biology program of the Sbarro Health Research Organization at the College of Science and Technology, Temple University (Philadelphia, US). 

In July 2016, Bucci left Biodigitalvalley and founded Resis Srl, a company dedicated to research integrity.

Since May 2017, he has served as an advisor to the CNR in a project to develop a software screening pipeline to foster the integrity and correctness of all research published by the CNR’s 7000 or so researchers.

Since 2022, he is part of the editorial board of Biology Direct, a BMC journal (Springer Nature).

Prof. Bucci’s research interests include:

1.     Research integrity, scientific fraud detection, and analysis

2.     Image Analysis;

3.     Network & Systems biology;

4.     Biological data mining and analytics;

5.     Big Data and social network analytics in the pharmaceutical field.